PCVX — Vaxcyte, Inc.
6 mentions in the last 24 hours · 0.03% of all mentions
Why people talked about PCVX (2026-11-05)
- Vaxcyte reported Q3 2026 GAAP EPS of -$1.99, beating estimates by $0.15.
- Revenue was reported as $0 with no analyst estimate published.
- Two executives, Cowan Elvia and Wassil Jim, sold shares on November 2, 2026.
| Bluesky | 4 | community |
| RSS Bundle | 1 | news |
| SEC EDGAR 8-K | 1 | filings |